跳至主要内容
临床试验/NCT05426655
NCT05426655已完成不适用

Effects of a Self-management Program for Temporomandibular Myalgia in Subjects With Fibromyalgia: a Single Arm Study

Jose Edgar Ferrandez Gomez1 个研究点 分布在 1 个国家目标入组 107 人开始时间: 2022年6月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
107
试验地点
1
主要终点
Change from the Baseline in the Oral Health-Related Quality of Life (OHRQoL)

研究概览

简要总结

Fibromyalgia is one of the most prevalent chronic widespread pain entities today. One of the most common problems in patients with fibromyalgia are alterations of the temporomandibular region, present in approximately 80% of the subjects, being, in turn, alterations of muscular origin the most common with a prevalence of 84%. One of the most promising therapeutic strategies is one that leads to self-management by the patient. The main objective of this study is to analyze the effect of a self-management program for myalgia in the temporomandibular region in subjects with fibromyalgia. For this, an experimental study of the uncontrolled Clinical Trial type will be carried out. Participants must be over 18 years of age, have a diagnosis of fibromyalgia and have myalgia or myofascial pain syndrome in the temporomandibular region. Demographic data, mandibular function, pain level, quality of life related to oral health, kinesiophobia, anxiety and depression, sleep, patient oral habits, catastrophizing, knowledge about pain, central sensitization, self-efficacy, coping with pain patient expectations, and patient satisfaction with the treatment received. An initial data collection will be carried out. The intervention will be carried out in 3 online sessions in which different pain processes will be explained, mandibular mobility exercises, masticatory muscle self-massage, as well as recommendations and advice on its pathology. Data will be collected again 4 weeks after the end of the program and at months 6 and 12. The appearance of adverse effects linked to the therapeutic program is not contemplated.

详细描述

Study design Analytical, prospective experimental study: uncontrolled clinical trial.

Population and study sample The study sample will be made up of subjects diagnosed with fibromyalgia who present with local myalgia, myofascial pain or referred myofascial pain in the temporomandibular region, according to the diagnostic criteria (DC/TMD). The subjects will be recruited after the mandatory acceptance and authorization by the corresponding bodies, during a recruitment period of approximately eight weeks, through different associations of fibromyalgia patients.

Intervention In a first visit, demographic data will be recorded and an examination will be performed to assess the presence of local myalgia, myofascial pain or referred myofascial pain in the temporomandibular region, according to the diagnostic criteria (DC/TMD). You will also be given, to read and sign, the informed consent for participation in the study, as well as the data protection document. After this visit, the defined eligibility criteria (inclusion and exclusion) will be applied.

In a second visit, a preliminary assessment will be carried out that will consist of mandibular function, pain level, quality of life related to oral health, kinesiophobia, anxiety and depression, sleep, patient oral habits, catastrophizing, knowledge about pain, central sensitization, self-efficacy, coping with pain patient expectations, and patient satisfaction with the treatment received.

One week later, the intervention program will begin. The program will consist of 3 online sessions (visits 3, 4 and 5) in which everything related to pain and its management will be explained. In a first workshop, a first educational session on the neurophysiology of pain will be given by means of a Power point presentation. In a second workshop, a tool will be used to locate those factors that can improve/worse the pain, physical documentation will be delivered with instructions for performing a self-massage and exercises of the temporomandibular region as well as advice and recommendations to manage different situations that may appear on a daily basis and on Lifestyle. A meditation session will also be held. In the third and last workshop, the game "the painometer" will be played and a meditation session will be held.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults over 18 years old.
  • Subjects diagnosed with fibromyalgia.
  • Orofacial pain of at least 3 months of evolution (considered chronic, according to IASP).
  • Presence of myalgia, local myalgia, myofascial pain or referred myofascial pain in the temporomandibular region (according to DC/TMD).

排除标准

  • Internal temporal-romandibular joint disorder with anterior disc displacement, joint pathology (arthritis), facial paralysis (active), mandibular fracture (active), infectious-inflammatory picture of odontogenic origin (active).
  • Pregnancy.
  • Neuropsychiatric pathologies (schizophrenia, bipolarity, cognitive alteration).
  • Subjects receiving any other physiotherapy treatment in the mandibular region.

研究组 & 干预措施

Self management

Experimental

Intervention group: education in pain neuroscience + self-massage + exercises + advice and recommendations.

干预措施: Self management (Other)

结局指标

主要结局

Change from the Baseline in the Oral Health-Related Quality of Life (OHRQoL)

时间窗: Baseline, 4 weeks after the end of the intervention, at month 6, at month 12.

Spanish version of Oral Health Impact Profile 5 items (OHIP-5 items).Responses are presented on a 5-point ordinal scale (0, never; 1, hardly ever; 2, occasionally; 3, fairly often; and 4, very often). Summing all responses resulted in a score ranging from a minimum of 0 to a maximum of 20. A larger score indicated more negative impacts of oral health problems.

次要结局

  • Change from the Baseline in the Fear of temporomandibular movement (kinesiophobia)(Baseline, 4 weeks after the end of the intervention, at month 6, at month 12.)
  • Change from the Baseline in pain maladaptation(Baseline, 4 weeks after the end of the intervention, at month 6, at month 12.)
  • Change from the Baseline in symptoms related to central sensitization(Baseline, 4 weeks after the end of the intervention at month 6, at month 12.)
  • Change from the Baseline in self-efficacy expectations(Baseline, 4 weeks after the end of the intervention, at month 6, at month 12.)
  • Change from the Baseline in pain coping strategies(Baseline, 4 weeks after the end of the intervention, at month 6, at month 12.)
  • Change from the Pain intensity(Baseline, 4 weeks after the end of the intervention, at month 6, at month 12.)
  • Change from the Baseline in the functional status of the masticatory system(Baseline, 4 weeks after the end of the intervention, at month 6, at month 12.)
  • Change from the Baseline in sleep difficulties(Baseline, 4 weeks after the end of the intervention, at month 6, at month 12.)
  • Change from the Baseline in emotional state(Baseline, 4 weeks after the end of the intervention, at month 6, at month 12.)
  • Change from the Baseline in oral behaviors(Baseline, 4 weeks after the end of the intervention, at month 6, at month 12.)
  • Change from the knowledge about neurophysiology of pain and conceptualization of pain(Baseline, 4 weeks after the end of the intervention, at month 6, at month 12.)
  • Treatment expectations(Pre-intervention)
  • Degree of satisfaction with the intervention(4 weeks after the end of the intervention)
  • Adverse effects(4 weeks after the end of the intervention)

研究者

发起方
Jose Edgar Ferrandez Gomez
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jose Edgar Ferrandez Gomez

Principal Investigator

Universidad de Murcia

研究点 (1)

Loading locations...

相似试验